Esther W. Bouman-Wammes

Benefits of Using Stereotactic Body Radiotherapy in Patients With Metachronous Oligometastases of Hormone-Sensitive Prostate Cancer Detected by [18F]fluoromethylcholine PET/CT

Esther W. Bouman-Wammes, Joyce M. van Dodewaard-de Jong, Max Dahele et al. · Clinical Genitourinary Cancer · 2017 · 40 citations

Adaptive Radiotherapy, Radiation Therapy, Medicine +8

A randomised phase II trial of docetaxel versus docetaxel plus carboplatin in patients with castration-resistant prostate cancer who have progressed after response to prior docetaxel chemotherapy: The RECARDO trial

Esther W. Bouman-Wammes, H. Pieter van den Berg, Linda de Munck et al. · European Journal of Cancer · 2017 · 26 citations

Urology, Docetaxel Chemotherapy, Genitourinary Cancer +8

Prognostic Value of [ 18 F]-Fluoromethylcholine Positron Emission Tomography/Computed Tomography Before Stereotactic Body Radiation Therapy for Oligometastatic Prostate Cancer

Matthijs C. F. Cysouw, Esther W. Bouman-Wammes, Otto S. Hoekstra et al. · International Journal of Radiation Oncology*Biology*Physics · 2018 · 15 citations

Radiation Therapy, Medical Imaging, Medicine +8

Predicting response to neoadjuvant chemotherapy with liquid biopsies and multiparametric MRI in patients with breast cancer

L. Janssen, Markus H. A. Janse, Bas B. L. Penning de Vries et al. · npj Breast Cancer · 2024 · 13 citations · Full text